Assistant / Associate / Full Professor - Academic Malignant Hematologist
About the role
Description:
The Division of Medical Oncology and Hematology at the Princess Margaret Cancer Centre, University Health Network (UHN) is seeking to recruit energetic and innovative physicians with expertise in malignant hematology; specifically with a keen interest in allogeneic hematopoietic cell transplantation (AlloHCT), to work within the Hans Messner Allogeneic Transplant Program. Each successful applicant will have an academic position description of either Clinician Teacher, Clinician in Quality & Innovation, or Clinician Investigator. Each successful applicant must be eligible for a Full Time Clinical Academic appointment at the rank of Assistant Professor or higher. The anticipated start date is October 01, 2025, or shortly thereafter.
Each successful applicant will have a demonstrated passion for the medical care of cancer patients as well as a strong interest in teaching and/or quality improvement. Each successful applicant will join a multidisciplinary team in the management of patients with hematological malignancies within a comprehensive cancer centre setting. In addition, the candidate will be expected to engage in clinical, translational, or basic research. Other responsibilities include teaching at the undergraduate and postgraduate levels.
Princess Margaret is home to one of the largest Hematology Programs across North America. Comprised of about forty senior physicians, the Malignant Hematology Program is supported by outstanding institutional infrastructure including Hematopathology, cytogenetics and molecular diagnostics programs led by a wide medical and allied health multidisciplinary team. The program supports extensive clinical, translational, and basic research initiatives including a large clinical trials program. Additionally, the Division of Medical Oncology and Hematology supports a comprehensive training program attracting both national and international fellows.
The Princess Margaret Cancer Centre includes the Princess Margaret Research Institute (formerly the Ontario Cancer Institute - OCI). This is a world-class basic and translational research institute with particular strengths in Genomics, Immunology, Stem Cell Biology, Cancer Biology, and Cell Therapeutics. The close association between clinicians and scientists provides the opportunity for collaborations on disease biology and the development of innovative and informative translational studies, allowing the applicant to achieve the goal of bench-to-bedside medicine. In addition, the Princess Margaret Cancer Centre supports active and widely recognized clinical trials and drug development programs and maintains a state-of-the-art GMP cell processing facility. Princess Margaret Cancer Centre is affiliated with the University of Toronto, which is world-recognized for programs in areas including Biochemistry, Immunology, Stem Cell Biology, Genomics, Proteomics, and Cell Processing, among others. Princess Margaret Cancer Centre is also a teaching hospital, dedicated to educating the world’s future top cancer experts. Our role as an internationally respected teaching hospital keeps us and our students abreast of the latest medical developments and the most advanced technology.
Each successful candidate must be a Hematologist and be eligible for a full time clinical academic appointment at the rank of Assistant Professor or higher. It is expected that the candidate will be hired into one of the University of Toronto Clinician Investigator, Clinician Teacher, or Clinician Quality & Innovation tracks. For applicants being considered for appointment as a Clinician Teacher, excellence will be assessed by the presence of scholarly contributions to teaching and education as evidenced by pedagogical innovation, curriculum development, experience in teaching at the undergraduate and graduate level, and teaching awards. For Clinician Investigators, scholarly excellence will be assessed by the presence of research grants, publications in leading journals, invited presentations at significant conferences, awards, accolades, and other related accomplishments. The applicant must also have, or be eligible for registration with the College of Physicians and Surgeons of Ontario and hold MD and FRCPC qualifications as well as Medical Oncology (or equivalent) specialist designation. Academic rank, salary and contractual arrangements will be commensurate with the qualifications and experience of the successful candidate. A highly attractive remuneration package is available.
Should you be interested in this opportunity, please forward your covering letter, curriculum vitae, and the names and addresses of three referees to:
Dr. Natasha Leighl - Chief, Division of Medical Oncology and Hematology
c/o Michelle Williams, Business Manager
Princess Margaret Cancer Centre, University Health Network
Suite 7-925, 700 University Avenue, Toronto, Ontario, Canada, M5G 1Z5
Office: 416.946.2341
Fax: 416.946.2082 E-mail: michelle.williams@uhn.ca
Applications will be accepted until September 3, 2025 or, until positions are filled.
For more information on the Princess Margaret Cancer Centre and our world-recognized programs, visit: www.theprincessmargaret.ca
For more information about the Department of Medicine, please visit our website at: http://www.deptmedicine.utoronto.ca/
CAUTION: This ad is “posted only” to the U of T affiliated hospital job board. Please see the information directly above for the application instructions; applications submitted via the "Apply Now" button on this page will NOT be considered for this position.
All qualified candidates are encouraged to apply; however, Canadians and permanent residents will be given priority.
Diversity Statement
The University of Toronto embraces Diversity and is building a culture of belonging that increases our capacity to effectively address and serve the interests of our global community. We strongly encourage applications from Indigenous Peoples, Black and racialized persons, women, persons with disabilities, and people of diverse sexual and gender identities. We value applicants who have demonstrated a commitment to equity, diversity and inclusion and recognize that diverse perspectives, experiences, and expertise are essential to strengthening our academic mission.
Accessibility Statement
The University strives to be an equitable and inclusive community, and proactively seeks to increase diversity among its community members. Our values regarding equity and diversity are linked with our unwavering commitment to excellence in the pursuit of our academic mission.
The University is committed to the principles of the Accessibility for Ontarians with Disabilities Act (AODA). As such, we strive to make our recruitment, assessment and selection processes as accessible as possible and provide accommodations as required for applicants with disabilities.
If you require any accommodations at any point during the application and hiring process, please contact uoft.careers@utoronto.ca.
Job Segment: Hematology, Immunology, Oncology, Biochemistry, Cytology, Healthcare, Science
About University of Toronto
Founded in 1827, the University of Toronto is Canada’s top university with a long history of challenging the impossible and transforming society through the ingenuity and resolve of our faculty, students, alumni, and supporters.
We are proud to be one of the world’s top research-intensive universities, bringing together top minds from every conceivable background and discipline to collaborate on the world’s most pressing challenges. As a catalyst for discovery, innovation, and progress, we prepare our students for success through an outstanding global education and commitment to inclusive excellence.
The ideas, innovations, and actions of more than 660,000 graduates advance U of T’s impact on communities across the globe.
Assistant / Associate / Full Professor - Academic Malignant Hematologist
About the role
Description:
The Division of Medical Oncology and Hematology at the Princess Margaret Cancer Centre, University Health Network (UHN) is seeking to recruit energetic and innovative physicians with expertise in malignant hematology; specifically with a keen interest in allogeneic hematopoietic cell transplantation (AlloHCT), to work within the Hans Messner Allogeneic Transplant Program. Each successful applicant will have an academic position description of either Clinician Teacher, Clinician in Quality & Innovation, or Clinician Investigator. Each successful applicant must be eligible for a Full Time Clinical Academic appointment at the rank of Assistant Professor or higher. The anticipated start date is October 01, 2025, or shortly thereafter.
Each successful applicant will have a demonstrated passion for the medical care of cancer patients as well as a strong interest in teaching and/or quality improvement. Each successful applicant will join a multidisciplinary team in the management of patients with hematological malignancies within a comprehensive cancer centre setting. In addition, the candidate will be expected to engage in clinical, translational, or basic research. Other responsibilities include teaching at the undergraduate and postgraduate levels.
Princess Margaret is home to one of the largest Hematology Programs across North America. Comprised of about forty senior physicians, the Malignant Hematology Program is supported by outstanding institutional infrastructure including Hematopathology, cytogenetics and molecular diagnostics programs led by a wide medical and allied health multidisciplinary team. The program supports extensive clinical, translational, and basic research initiatives including a large clinical trials program. Additionally, the Division of Medical Oncology and Hematology supports a comprehensive training program attracting both national and international fellows.
The Princess Margaret Cancer Centre includes the Princess Margaret Research Institute (formerly the Ontario Cancer Institute - OCI). This is a world-class basic and translational research institute with particular strengths in Genomics, Immunology, Stem Cell Biology, Cancer Biology, and Cell Therapeutics. The close association between clinicians and scientists provides the opportunity for collaborations on disease biology and the development of innovative and informative translational studies, allowing the applicant to achieve the goal of bench-to-bedside medicine. In addition, the Princess Margaret Cancer Centre supports active and widely recognized clinical trials and drug development programs and maintains a state-of-the-art GMP cell processing facility. Princess Margaret Cancer Centre is affiliated with the University of Toronto, which is world-recognized for programs in areas including Biochemistry, Immunology, Stem Cell Biology, Genomics, Proteomics, and Cell Processing, among others. Princess Margaret Cancer Centre is also a teaching hospital, dedicated to educating the world’s future top cancer experts. Our role as an internationally respected teaching hospital keeps us and our students abreast of the latest medical developments and the most advanced technology.
Each successful candidate must be a Hematologist and be eligible for a full time clinical academic appointment at the rank of Assistant Professor or higher. It is expected that the candidate will be hired into one of the University of Toronto Clinician Investigator, Clinician Teacher, or Clinician Quality & Innovation tracks. For applicants being considered for appointment as a Clinician Teacher, excellence will be assessed by the presence of scholarly contributions to teaching and education as evidenced by pedagogical innovation, curriculum development, experience in teaching at the undergraduate and graduate level, and teaching awards. For Clinician Investigators, scholarly excellence will be assessed by the presence of research grants, publications in leading journals, invited presentations at significant conferences, awards, accolades, and other related accomplishments. The applicant must also have, or be eligible for registration with the College of Physicians and Surgeons of Ontario and hold MD and FRCPC qualifications as well as Medical Oncology (or equivalent) specialist designation. Academic rank, salary and contractual arrangements will be commensurate with the qualifications and experience of the successful candidate. A highly attractive remuneration package is available.
Should you be interested in this opportunity, please forward your covering letter, curriculum vitae, and the names and addresses of three referees to:
Dr. Natasha Leighl - Chief, Division of Medical Oncology and Hematology
c/o Michelle Williams, Business Manager
Princess Margaret Cancer Centre, University Health Network
Suite 7-925, 700 University Avenue, Toronto, Ontario, Canada, M5G 1Z5
Office: 416.946.2341
Fax: 416.946.2082 E-mail: michelle.williams@uhn.ca
Applications will be accepted until September 3, 2025 or, until positions are filled.
For more information on the Princess Margaret Cancer Centre and our world-recognized programs, visit: www.theprincessmargaret.ca
For more information about the Department of Medicine, please visit our website at: http://www.deptmedicine.utoronto.ca/
CAUTION: This ad is “posted only” to the U of T affiliated hospital job board. Please see the information directly above for the application instructions; applications submitted via the "Apply Now" button on this page will NOT be considered for this position.
All qualified candidates are encouraged to apply; however, Canadians and permanent residents will be given priority.
Diversity Statement
The University of Toronto embraces Diversity and is building a culture of belonging that increases our capacity to effectively address and serve the interests of our global community. We strongly encourage applications from Indigenous Peoples, Black and racialized persons, women, persons with disabilities, and people of diverse sexual and gender identities. We value applicants who have demonstrated a commitment to equity, diversity and inclusion and recognize that diverse perspectives, experiences, and expertise are essential to strengthening our academic mission.
Accessibility Statement
The University strives to be an equitable and inclusive community, and proactively seeks to increase diversity among its community members. Our values regarding equity and diversity are linked with our unwavering commitment to excellence in the pursuit of our academic mission.
The University is committed to the principles of the Accessibility for Ontarians with Disabilities Act (AODA). As such, we strive to make our recruitment, assessment and selection processes as accessible as possible and provide accommodations as required for applicants with disabilities.
If you require any accommodations at any point during the application and hiring process, please contact uoft.careers@utoronto.ca.
Job Segment: Hematology, Immunology, Oncology, Biochemistry, Cytology, Healthcare, Science
About University of Toronto
Founded in 1827, the University of Toronto is Canada’s top university with a long history of challenging the impossible and transforming society through the ingenuity and resolve of our faculty, students, alumni, and supporters.
We are proud to be one of the world’s top research-intensive universities, bringing together top minds from every conceivable background and discipline to collaborate on the world’s most pressing challenges. As a catalyst for discovery, innovation, and progress, we prepare our students for success through an outstanding global education and commitment to inclusive excellence.
The ideas, innovations, and actions of more than 660,000 graduates advance U of T’s impact on communities across the globe.